SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-24-067223
Filing Date
2024-05-31
Accepted
2024-05-31 16:30:38
Documents
1
Effectiveness Date
2024-05-31
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9430
  Complete submission text file 0001104659-24-067223.txt   10798
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-514857 | Film No.: 241010256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)